Search company, investor...
BioTrove company logo


Founded Year



Acquired | Acquired

Total Raised


About BioTrove

BioTrove's platforms include OpenArray, developed for use in genomic research in different life science fields, including disease analysis. The other platform is RapidFire, which enables the acceleration of drug discovery and pipeline decisions.

Headquarters Location

12 Gill Street Suite 4000

Woburn, Massachusetts, 01801,

United States


Missing: BioTrove's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BioTrove's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing BioTrove

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioTrove is included in 1 Expert Collection, including Omics.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

BioTrove Patents

BioTrove has filed 3 patents.

patents chart

Application Date

Grant Date


Related Topics




Drug discovery, Biotechnology, Printed circuit board manufacturing, Soldering, Electronics manufacturing


Application Date


Grant Date



Related Topics

Drug discovery, Biotechnology, Printed circuit board manufacturing, Soldering, Electronics manufacturing



Latest BioTrove News

Life Technologies Acquiring BioTrove

Jul 28, 2017

Life Technologies (NASDAQ: LIFE ), the Carlsbad, CA-based provider of biotech instruments and lab supplies, says it has agreed to acquire Woburn, MA-based BioTrove, which has developed a high throughput gene expression and genotyping analysis system. BioTrove, which withdrew plans to raise $75 million in an IPO last year, says the flexible array format of its OpenArray technology enables researchers to perform more than 3,000 PCR or qPCR gene expression assays at a time. Financial terms were not disclosed. Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at or call (619) 669-8788 Follow @bvbigelow

BioTrove Frequently Asked Questions (FAQ)

  • When was BioTrove founded?

    BioTrove was founded in 1997.

  • Where is BioTrove's headquarters?

    BioTrove's headquarters is located at 12 Gill Street, Woburn.

  • What is BioTrove's latest funding round?

    BioTrove's latest funding round is Acquired.

  • How much did BioTrove raise?

    BioTrove raised a total of $56.75M.

  • Who are the investors of BioTrove?

    Investors of BioTrove include Life Technologies Corporation, Fletcher Spaght Ventures, CB Health Ventures, Catalyst Health Ventures, Echelon Ventures and 7 more.

  • Who are BioTrove's competitors?

    Competitors of BioTrove include Visiopharm, Fluxion Biosciences, BioNano Genomics, Sword Diagnostics, Aushon BioSystems, Quanterix, IntelliCyt, Applied Precision, ADMETRx, Anthill Technologies and 16 more.

Compare BioTrove to Competitors

Genomic Solutions

The scientists at Genomic Solutions have a wealth of genomic, protein analysis and nano-liter dispensing application-based expertise that they would like to share with users. First select their area of research, followed by interest and then application, and finally, to the company's instrumentation which can help facilitate their research. Whether users are involved in the life science or biotechnology research community, the company's products will enable users to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. You achieve rapid and less expensive drug discovery.

Sword Diagnostics

Sword Diagnostics is a life sciences company created in response to the needs of the research, pharmaceutical, and clinical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and diseased-related biological processes, today's life science tools are unable to effectively measure, quantify, and determine the ultimate value of these biological markers. Sword Diagnostics' technology is directly aimed at making it easier to understand these newly emerging biomarkers, as well as extending the utility of existing diagnostics assays. Sword's mission is to provide the next-generation detection technology to life scientists, enabling them to continue advances in medical research, drug discovery and the provision of health care products and services.

Fluxion Biosciences Logo
Fluxion Biosciences

Fluxion Biosciences is a developer of precision solutions for life science research and diagnostics. Fluxion's liquid biopsy solutions are changing how cancer is detected and treated. Fluxion's pioneering liquid biopsy technologies include the IsoFlux CTC Liquid Biopsy System, ERASE-Seq ultra-sensitive variant caller, and the Spotlight 59 NGS Oncology Panel for cancer mutation detection from cell-free circulating tumor DNA. Fluxion's technologies are used globally by cancer centers developing new tests for early cancer detection and patient monitoring.


PlexPress is a life science company doing work in gene expression analysis technology to advance biological science, drug discovery, crop science and diagnostics. PlexPress seeks to rapidly provide reliable information at low cost. Its products simultaneously measure multiple genes from multiple samples. PlexPress operates from Los Altos, California and Helsinki, Finland.


Vivonetics a company created through Georgia Tech's VentureLab program. The company is developing applications for molecular beacon technology in life science research and drug discovery. Its initial focus is on probes to detect RNA in living cells.

Gentronix Limited

Gentronix provides toxicology testing services for pharmaceuticals, agrochemicals, cosmetics, personal care and consumer products. The company enables major global brands to perform hazard and safety assessments, from early-stage discovery through to regulatory submission and approval.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.